EU to cease holdup of Indian generics

It's not exactly peace in the Middle East, but India and Europe appear to have settled their trade differences. India says it will withdraw its WTO complaint against the EU, while EU officials say they will stop claiming patent infringement while delaying Indian generic-drug shipments. Story

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.